Increased expression of PRMT1 has been implicated in the tumorigenesis of multiple cancers including progesterone receptor positive breast cancer, hepatocellular carcinoma (HCC), neuroblastoma, and pancreatic cancer [35,36,37,38]. The gene discussed is PRMT1; the disease is pancreatic neoplasm.